Clinical and preclinical trials of breast cancer

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985904%3A_____%2F19%3A00510267" target="_blank" >RIV/67985904:_____/19:00510267 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1088/2053-2563/ab2907ch11" target="_blank" >http://dx.doi.org/10.1088/2053-2563/ab2907ch11</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1088/2053-2563/ab2907ch11" target="_blank" >10.1088/2053-2563/ab2907ch11</a>

Result language
angličtina
Original language name
Clinical and preclinical trials of breast cancer
Original language description
Breast cancer (BC) is the second-most common cause of cancer-related deaths and it is caused by metastatic BC (MBC). This chapter stresses the inadequate success of traditional therapies as well as the use of nanomedicine for treating BC. An overview of nanomedicines applied inBC therapy is summarized with their present status, which is attaining attention in the pre-clinically as well as clinically applied landscape. Here we highlight the biology of MBC, the nanomaterial used for BC. Furthermore, the types, strategies and challenges in preclinical and clinical trials are explored in detail.
Czech name
—
Czech description
—

Project
<a href="/en/project/LO1609" target="_blank" >LO1609: Models of the Serious Human Diseases: Traumatic Spinal Cord Injury, Huntington’s Disease, Melanoma and Infertility</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Book/collection name
External Field and Radiation Stimulated Breast Cancer Nanotheranostics
ISBN
978-0-7503-2414-4
Number of pages of the result
19
Pages from-to
11-1-11-19
Number of pages of the book
351
Publisher name
IOP Publishing
Place of publication
Washington
UT code for WoS chapter
—

Similar results(10)